Stable protein formulations
The present invention relates generally to stable formulations comprising CTLA4Ig molecules, including lyophilized, and liquid formulations for administration via various routes including, for example, routes such as intravenous (IV) and subcutaneous (SC) for treating immune system diseases and tole...
Saved in:
Main Authors | , , , , , |
---|---|
Format | Patent |
Language | English |
Published |
05.07.2007
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The present invention relates generally to stable formulations comprising CTLA4Ig molecules, including lyophilized, and liquid formulations for administration via various routes including, for example, routes such as intravenous (IV) and subcutaneous (SC) for treating immune system diseases and tolerance induction. |
---|---|
AbstractList | The present invention relates generally to stable formulations comprising CTLA4Ig molecules, including lyophilized, and liquid formulations for administration via various routes including, for example, routes such as intravenous (IV) and subcutaneous (SC) for treating immune system diseases and tolerance induction. |
Author | VIJAY H. NARINGREKAR RAJESH B. GANDHI CHARLES E. DAHLHEIM MANISHA M. DALI MANOJ NERURKAR SUNITA BORSADIA |
Author_xml | – fullname: MANISHA M. DALI – fullname: RAJESH B. GANDHI – fullname: SUNITA BORSADIA – fullname: CHARLES E. DAHLHEIM – fullname: MANOJ NERURKAR – fullname: VIJAY H. NARINGREKAR |
BookMark | eNrjYmDJy89L5WSQDi5JTMpJVSgoyi9JzcxTSMsvyi3NSSzJzM8r5mFgTUvMKU7lhdLcDMpuriHOHrqpBfnxqcUFicmpeakl8Y6hRgYGZsbGBqaWxo6GxsSpAgD8qyZN |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences |
ExternalDocumentID | AU2006330593A1 |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_AU2006330593A13 |
IEDL.DBID | EVB |
IngestDate | Fri Jul 19 14:20:54 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_AU2006330593A13 |
Notes | Application Number: AU20060330593 |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20070705&DB=EPODOC&CC=AU&NR=2006330593A1 |
ParticipantIDs | epo_espacenet_AU2006330593A1 |
PublicationCentury | 2000 |
PublicationDate | 20070705 |
PublicationDateYYYYMMDD | 2007-07-05 |
PublicationDate_xml | – month: 07 year: 2007 text: 20070705 day: 05 |
PublicationDecade | 2000 |
PublicationYear | 2007 |
RelatedCompanies | BRISTOL-MYERS SQUIBB COMPANY |
RelatedCompanies_xml | – name: BRISTOL-MYERS SQUIBB COMPANY |
Score | 2.6767044 |
Snippet | The present invention relates generally to stable formulations comprising CTLA4Ig molecules, including lyophilized, and liquid formulations for administration... |
SourceID | epo |
SourceType | Open Access Repository |
SubjectTerms | CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES |
Title | Stable protein formulations |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20070705&DB=EPODOC&locale=&CC=AU&NR=2006330593A1 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQMbM0Tk00NEvVNUu2SAJ2UAwtdBNN01J0TROBFWxyiqVRSgpoc7Kvn5lHqIlXhGkEE0MObC8M-JzQcvDhiMAclQzM7yXg8roAMYjlAl5bWayflAkUyrd3C7F1UYP1js2B0FTNxcnWNcDfxd9ZzdkZ2JNU8wsC95yBXXdTS2NHYF-JFdiQNgflB9cwJ9C-lALkSsVNkIEtAGheXokQA1NqnjADpzPs7jVhBg5f6JQ3kAnNfcUiDNLAlmFSTqoC-GyFzDwFUHsTevtWsSiDsptriLOHLtCWeLin4h1DkZ1kLMbAAuzup0owKKQZplmaJJmlWSSampskplpYWKakJScCW_aGacnGiamGkgwy-EySwi8tzcAFG500MJVhYCkpKk2VBVarJUly4NAAAGY6exY |
link.rule.ids | 230,309,783,888,25576,76876 |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_GFOebTsW5qQWlb0Vrm348DNn6QdW1G9LJ3kraJjAYddiK_77X0OqeRl5CApcP-OXul-TuAO4NW2NUNZhiZFaKBEW1FEp4rhCKCjbL7ac8r52Tw8gIlvrriqw6sGl9YUSc0B8RHBERlSHeK3Feb_8vsVzxt7J8SNfY9Pnsx2NXbtmxiYXI7nTsLebu3JEdB5mkHL0L5ozUndjaBLnSARrZZo0H72Na-6Vsd5WKfwKHC5RXVKfQYUUfek6be60PR2Hz5I3VBn3lGQzRMkw3TBKxFdaFVNubTfat8hzufC92AgVHSf4WlUyWu1PSLqCLdJ9dgsRVbuupwS1KTJ0yy7JznlG07FWeaZSpAxjtk3S1v_sWekEczpLZS_Q2hOP2pvKRjKBbfX2za1SxVXojduYXVmx-CQ |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Stable+protein+formulations&rft.inventor=MANISHA+M.+DALI&rft.inventor=RAJESH+B.+GANDHI&rft.inventor=SUNITA+BORSADIA&rft.inventor=CHARLES+E.+DAHLHEIM&rft.inventor=MANOJ+NERURKAR&rft.inventor=VIJAY+H.+NARINGREKAR&rft.date=2007-07-05&rft.externalDBID=A1&rft.externalDocID=AU2006330593A1 |